Jul 7, 2023

BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia

BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute lymphoblastic leukemia.

Comments

Children with congenital heart defects found to have poorer survival following cancer diagnosis

‘Overwhelming evidence’ that common products are fuelling huge surge in childhood cancer cases, scientists warn

Understanding common challenges in childhood cancer treatment

Obesity at diagnosis predicts poorer survival for children with cancer

Bone Mineral Density Deficits Prevalent Among Childhood Cancer Survivors

Cutting-edge immunotherapy offers hope for relapsed brain tumors

AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns

New Research Shows Inherited Genetic Variants Increase Risk of Certain Pediatric Cancers

Menin inhibitor clinical trial puts pediatric leukemia patient in remission

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Recent Posts

BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia

Comments

Children with congenital heart defects found to have poorer survival following cancer diagnosis

‘Overwhelming evidence’ that common products are fuelling huge surge in childhood cancer cases, scientists warn

Understanding common challenges in childhood cancer treatment

Obesity at diagnosis predicts poorer survival for children with cancer

Bone Mineral Density Deficits Prevalent Among Childhood Cancer Survivors

Cutting-edge immunotherapy offers hope for relapsed brain tumors

AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns

New Research Shows Inherited Genetic Variants Increase Risk of Certain Pediatric Cancers

Menin inhibitor clinical trial puts pediatric leukemia patient in remission

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Archive

Search By Tags